A PHARMACOKINETIC AND SAFETY STUDY OF MAXIVENT(R) (DOXOFYLLINE [D]) TREATMENT IN SUBJECTS WITH CLASS-A OR CLASS-B HEPATIC IMPAIRMENT

Authors
JUMA MA OCONNELL K HU W MIGDALOF BH HARNING R
Citation
Ma. Juma et al., A PHARMACOKINETIC AND SAFETY STUDY OF MAXIVENT(R) (DOXOFYLLINE [D]) TREATMENT IN SUBJECTS WITH CLASS-A OR CLASS-B HEPATIC IMPAIRMENT, Journal of allergy and clinical immunology, 95(1), 1995, pp. 355-355
Citations number
NO
Categorie Soggetti
Immunology,Allergy
Journal title
Journal of allergy and clinical immunology → ACNP
ISSN journal
00916749
Volume
95
Issue
1
Year of publication
1995
Part
2
Pages
355 - 355
Database
ISI
SICI code
0091-6749(1995)95:1<355:APASSO>2.0.ZU;2-R